[Efficacy and toxicity of immune checkpoint inhibitors in elderly patients - 5th edition of the congress of pharmacology of anticancer drugs]. [electronic resource]
Producer: 20190110Description: 1202-1208 p. digitalISSN:- 1769-6917
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents, Immunological -- adverse effects
- B7-H1 Antigen -- antagonists & inhibitors
- CTLA-4 Antigen -- antagonists & inhibitors
- Humans
- Immunosenescence
- Immunotherapy -- adverse effects
- Neoplasms -- therapy
- Nivolumab -- therapeutic use
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.